Medicines Evaluation Unit

541 papers and 16.0k indexed citations i.

About

In recent decades, authors affiliated with Medicines Evaluation Unit have published 541 papers, which have received a total of 16.0k indexed citations. Scholars at this organization have produced 285 papers in Pulmonary and Respiratory Medicine, 231 papers in Physiology and 46 papers in Epidemiology on the topics of Asthma and respiratory diseases (219 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (212 papers) and Respiratory and Cough-Related Research (85 papers). Their work is cited by papers focused on Pulmonary and Respiratory Medicine (6.8k citations), Physiology (5.6k citations) and Cardiology and Cardiovascular Medicine (1.6k citations). Authors at Medicines Evaluation Unit collaborate with scholars in United Kingdom, United States and The Netherlands and have published in prestigious journals including New England Journal of Medicine, The Lancet and Circulation. Some of Medicines Evaluation Unit's most productive authors include Dave Singh, Nick Freemantle, James Mason, Jørgen Vestbo, Philip J. Young, Paul F. M. Krabbe, Jayne Harrison, John G.F. Cleland, John Geddes and Paul J. Harrison.

In The Last Decade

Fields of papers published by authors at Medicines Evaluation Unit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Medicines Evaluation Unit at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Medicines Evaluation Unit at the time of their publication.

Countries citing scholars working at Medicines Evaluation Unit

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Medicines Evaluation Unit. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Medicines Evaluation Unit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medicines Evaluation Unit more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025